Byondis to Present Data from its Novel ADC Technology Platforms at the…

NIJMEGEN, The Netherlands--(Business Wire/Korea Newswire)--Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, will profile the Company’s first-in-class antifolate and phosphonate...